Targeted Downregulation of kdm4a Ameliorates Tau-engendered Defects in Drosophila melanogaster.

Published in: Journal of Korean medical science (2019)

Our results suggest that downregulation of kdm4a expression may be a potential therapeutic target in AD.

Keyphrases